International Journal of Clinical Case Reports, 2025, Vol.15, No.5, 239-247 http://medscipublisher.com/index.php/ijmms 246 Conflict of Interest Disclosure The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Chaanine A.H., Kohlbrenner E., Gamb S.I., Guenzel A.J., Klaus K., Fayyaz A.U., Nair K.S., Hajjar R.J., and Redfield M.M., 2016, FOXO3a regulates BNIP3 and modulates mitochondrial calcium dynamics and function in cardiac stress, American Journal of Physiology-Heart and Circulatory Physiology, 311(6): H1540-H1559. https://doi.org/10.1152/ajpheart.00549.2016 Chang Z.S., Xia J.B., Wu H.Y., Peng W.T., Jiang F.Q., Li J., Liang C.Q., Zhao H., Park K.S., Song G.H., Kim S.K., Huang R.J., Zheng L., Cai D.Q., and Qi X.F., 2019, Forkhead box O3 protects the heart against paraquat‐induced aging‐associated phenotypes by upregulating the expression of antioxidant enzymes, Aging Cell, 18(5): e12990. https://doi.org/10.1111/acel.12990 Deng A., Ma L., Zhou X., Wang X., Wang S., and Chen X., 2021, FoxO3 transcription factor promotes autophagy after oxidative stress injury in HT22 cells, Canadian Journal of Physiology and Pharmacology, 99(6): 627-634. https://doi.org/10.1139/cjpp-2020-0448 Fasano C., Disciglio V., Bertora S., Lepore Signorile M., and Simone C., 2019, FOXO3a from the nucleus to the mitochondria: a round trip in cellular stress response, Cells, 8(9): 1110. https://doi.org/10.3390/cells8091110 Furukawa-Hibi Y., Kobayashi Y., Chen C., and Motoyama N., 2005, FOXO transcription factors in cell-cycle regulation and the response to oxidative stress, Antioxidants and Redox Signaling, 7(5-6): 752-760. https://doi.org/10.1089/ars.2005.7.752 Hollenberg S.M., and Singer M., 2021, Pathophysiology of sepsis-induced cardiomyopathy, Nature Reviews Cardiology, 18(6): 424-434. https://doi.org/10.1038/s41569-020-00492-2 Hou D., Liao H., Hao S., Liu R., Huang H., and Duan C., 2024, Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1/PGC-1α pathway, Heliyon, 10(7): e28501. https://doi.org/10.1016/j.heliyon.2024.e28501 Hu S., Zhang C., Qian T., Bai Y., Chen L., Chen J., Huang C., Xie C., Wang X., and Jin H., 2021, Promoting Nrf2/Sirt3‐dependent mitophagy suppresses apoptosis in nucleus pulposus cells and protects against intervertebral disc degeneration, Oxidative Medicine and Cellular Longevity, 2021(1): 6694964. https://doi.org/10.1155/2021/6694964 Jacobs K.M., Pennington J.D., Bisht K.S., Aykin-Burns N., Kim H.S., Mishra M., Sun L., Nguyen P., Ahn B.H., Leclerc J., Deng C.X., Spitz D.R., and Gius D., 2008, SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria as well as increases FOXO3a dependent gene expression, International Journal of Biological Sciences, 4(5): 291. https://doi.org/10.7150/ijbs.4.291 Kim A., Koo J.H., Lee J.M., Joo M.S., Kim T.H., Kim H., Jun D.W., and Kim S.G., 2022, NRF2‐mediated SIRT3 induction protects hepatocytes from ER stress‐induced liver injury, The FASEB Journal, 36(3): e22170. https://doi.org/10.1096/fj.202101470R Kokkinaki D., Hoffman M., Kalliora C., Kyriazis I.D., Maning J., Lucchese A.M., Shanmughapriya S., Tomar D., Park J.Y., Wang H., Yang X.F., Madesh M., Lymperopoulos A., Koch W.J., Christofidou-Solomidou M., and Drosatos K., 2019, Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy, Journal of Molecular and Cellular Cardiology, 127: 232-245. https://doi.org/10.1016/j.yjmcc.2018.12.016 Murugasamy K., Munjal A., and Sundaresan N.R., 2022, Emerging roles of SIRT3 in cardiac metabolism, Frontiers in Cardiovascular Medicine, 9: 850340. https://doi.org/10.3389/fcvm.2022.850340 Ning Y., Dou X., Wang Z., Shi K., Wang Z., Ding C., Sang X., Zhong X., Shao M., Han X., and Cao G., 2024, SIRT3: a potential therapeutic target for liver fibrosis, Pharmacology and Therapeutics, 257: 108639. https://doi.org/10.1016/j.pharmthera.2024.108639 Peng F., Liao M., Jin W., Liu W., Li Z., Fan Z., Zou L., Chen S., Zhu L., Zhao Q., Zhan G., Ouyang L., Peng C., Bo Han B., Ma Zhang J., and Fu L.L., 2024, 2-APQC a small-molecule activator of Sirtuin-3 (SIRT3) alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis, Signal Transduction and Targeted Therapy, 9(1): 133. https://doi.org/10.1038/s41392-024-01816-1 Qin S., Ren Y., Feng B., Wang X., Liu J., Zheng J., Li K., Mei H., Dai Q., Yu H., and Fu X., 2024, Annexin-A1 short peptide alleviates septic myocardial injury by upregulating SIRT3 and inhibiting myocardial cell apoptosis, Histol Histopathol, 39: 947-957. Schips T.G., Wietelmann A., Höhn K., Schimanski S., Walther P., Braun T., Wirth T., and Maier H.J., 2011, FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model, Cardiovascular Research, 91(4): 587-597. https://doi.org/10.1093/cvr/cvr144 Trinh D., Al Halabi L., Brar H., Kametani M., and Nash J.E., 2024, The role of SIRT3 in homeostasis and cellular health, Frontiers in Cellular Neuroscience, 18: 1434459. https://doi.org/10.3389/fncel.2024.1434459
RkJQdWJsaXNoZXIy MjQ4ODYzNA==